We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current CADL market cap is 257.39M. The company's latest EPS is USD -1.3119 and P/E is -6.88.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 31k | 31k | 0 | 0 | 0 |
| Operating Income | -8.88M | -8.1M | -9.63M | -9.58M | -8.86M |
| Net Income | -8.69M | -5.08M | -8.8M | -9.61M | -8.44M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 125k | 125k | 0 |
| Operating Income | -25.73M | -34.72M | -38.39M |
| Net Income | -36.12M | -18.79M | -37.94M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 85.01M | 77.69M | 67.24M | 58.71M | 50.06M |
| Total Liabilities | 32.88M | 29.98M | 27.59M | 27.94M | 27.04M |
| Total Equity | 52.13M | 47.71M | 39.65M | 30.77M | 23.02M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.21M | 77.69M | 41.2M |
| Total Liabilities | 25.07M | 29.98M | 28.46M |
| Total Equity | 64.14M | 47.71M | 12.75M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -24.53M | -31.42M | -10.82M | -18.01M | -26.82M |
| Investing | -1.02M | -1.3M | 19k | -150k | -253k |
| Financing | 19.94M | 19.97M | N/A | N/A | N/A |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -22.22M | -31.42M | -34.24M |
| Investing | -1.84M | -1.3M | -280k |
| Financing | 71.8M | 19.97M | -121k |
| Market Cap | 257.39M |
| Price to Earnings Ratio | -6.88 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 7.37 |
| Price to Book Ratio | 20.47 |
| Dividend Yield | - |
| Shares Outstanding | 28.92M |
| Average Volume (1 week) | 844.25k |
| Average Volume (1 Month) | 9.29M |
| 52 Week Change | 429.76% |
| 52 Week High | 11.3999 |
| 52 Week Low | 0.66 |
| Spread (Intraday) | 4.55 (46.33%) |
| Company Name | Candel Therapeutics Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.candeltx.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
